Temozolomide (TMZ)
Showing 1 - 25 of 892
6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly
Withdrawn
- MGMT-Methylated Glioblastoma
- Delay of TMZ
- Standard of Care (SOC) Adjuvant TMZ (no intervention
- (no location specified)
Aug 5, 2022
Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))
Active, not recruiting
- Glioblastoma
- Ibrutinib
- +2 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 30, 2023
Standard Radiotherapy and TMZ Patients With GBM
Not yet recruiting
- Glioblastoma
- Glioma, Malignant
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke University
Jan 20, 2023
Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))
Recruiting
- Glioblastoma
- GBM
- XS005 Cell Injection
- Temozolomide(TMZ)
-
Suzhou, Jiangsu, ChinaDushu Lake Hospital Affiliated to Soochow University
Nov 23, 2023
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Worldwide (SonoCloud-9 (SC9), Carboplatin, Lomustine)
Not yet recruiting
- Glioblastoma
- +2 more
- SonoCloud-9 (SC9)
- +3 more
-
Chicago, Illinois
- +7 more
Jun 5, 2023
Glioblastoma Multiforme Trial in Cleveland (biological, drug, other, procedure, radiation)
Active, not recruiting
- Glioblastoma Multiforme
- MGMTP140K-encoding retroviral vector
- +6 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
May 6, 2022
Glioblastoma Trial in Birmingham (Autologous genetically modified gamma-delta T cells, Allogeneic genetically modified
Not yet recruiting
- Glioblastoma
- Autologous genetically modified gamma-delta T cells
- Allogeneic genetically modified gamma-delta T cells
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 16, 2022
Glioblastoma, Glioblastoma, WHO Grade IV Trial in Gainesville (Temozolomide (TMZ), Optune System, Pembrolizumab)
Active, not recruiting
- Glioblastoma
- Glioblastoma, WHO Grade IV
- Temozolomide (TMZ)
- +2 more
-
Gainesville, FloridaUniversity of Florida Health
Aug 22, 2022
Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,
Not yet recruiting
- Glioblastoma Multiforme
- +3 more
- P140K-MGMT
- +5 more
-
Bethesda, Maryland
- +1 more
Jul 4, 2022
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)
Active, not recruiting
- Glioblastoma
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 16, 2022
Glioblastoma Trial (Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide))
Not yet recruiting
- Glioblastoma
- Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)
- (no location specified)
Apr 20, 2022
Glioma of Brain Trial in Orange (Mirtazapine (Remeron))
Recruiting
- Glioma of Brain
- Mirtazapine (Remeron)
-
Orange, CaliforniaUC Irvine Health/Chao Family Comprehensive Cancer Center
Dec 26, 2022
Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)
Not yet recruiting
- Newly Diagnosed Glioblastoma
- [177Lu]Lu-NeoB
- +2 more
- (no location specified)
Feb 13, 2023
Recurrent Glioblastoma Trial in Beijing (Laser interstitial thermal therapy, Temozolomide)
Active, not recruiting
- Recurrent Glioblastoma
- Laser interstitial thermal therapy
- Temozolomide
-
Beijing, ChinaBeijing Tiantan Hospital
Dec 22, 2022
Anaplastic Oligoastrocytoma, Glioblastoma Trial in Guangzhou (Temozolomide)
Recruiting
- Anaplastic Oligoastrocytoma
- Glioblastoma
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Oct 27, 2022
Gastrointestinal Stromal Tumors, Sdh, GIST Trial in United States (Temozolomide)
Recruiting
- Gastrointestinal Stromal Tumors
- +3 more
-
La Jolla, California
- +4 more
Aug 17, 2021
Acral Melanoma Trial (camrelizumab+apatinib+TMZ, camrelizumab+apatinib, camrelizumab)
Not yet recruiting
- Acral Melanoma
- camrelizumab+apatinib+TMZ
- +2 more
- (no location specified)
Mar 16, 2023
Colorectal Cancer Trial in New Haven (Temozolomide + Olaparib)
Active, not recruiting
- Colorectal Cancer
- Temozolomide + Olaparib
-
New Haven, ConnecticutYale New Haven Hospital
Aug 17, 2022
Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine
Recruiting
- Glioblastoma, IDH-wildtype
- +4 more
- Eflornithine (Dose Level 1)
- +3 more
-
Cleveland, OhioThe Cleveland Clinic
May 19, 2023
Glioblastoma, Glioblastoma Multiforme Trial in United States (drug, other, radiation)
Recruiting
- Glioblastoma
- Glioblastoma Multiforme
- BPM31510
- +3 more
-
Los Angeles, California
- +3 more
May 31, 2022
Brain Tumor, Astrocytoma, Astroglioma Trial run by the NCI (Zotiraciclib (TG02), Temozolomide (TMZ))
Completed
- Brain Tumor
- +4 more
- Zotiraciclib (TG02)
- Temozolomide (TMZ)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 3, 2021
Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)
Active, not recruiting
- Breast Cancer
- +3 more
-
Boston, Massachusetts
- +2 more
Dec 21, 2022
Glioblastoma Trial in Boston (radiation, biological, drug)
Recruiting
- Glioblastoma
- Radiation Therapy
- +3 more
-
Boston, Massachusetts
- +1 more
May 31, 2022